Med-IQ Logo
Get CME/CE
Case Simulations in Metastatic Melanoma: Navigating Complex Treatment Decisions
Simulation Simulation

Case Simulations in Metastatic Melanoma: Navigating Complex Treatment Decisions


Time to Complete:
1 hour
Released:
12/23/16
Expires:
1/22/18

Maximum Credits:

1.0 AMA PRA Category 1 Credit(s)
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Simulation Simulation
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.
Time to Complete:
1 hour

Released:
12/23/16

Expires:
1/22/18

Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
Share on:
Simulation Simulation
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Share on:


Time to Complete:
1 hour
Released:
12/23/16
Expires:
1/22/18


Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)


Overview: In these video-enhanced, CME-certified, case-based simulations, clinicians are challenged to select first- and subsequent-line treatment regimens for two fictional patients with stage IV melanoma. Throughout the activity, clinicians must consider patient- and tumor-related characteristics, patient preferences, and contemporary evidence to make appropriate management decisions.

Faculty

Adil I. Daud, MD

Clinical Professor,Department of Medicine

Director, Melanoma Clinical Research

University of California, San Francisco Medical Center

San Francisco, CA


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Adil I. Daud, MD
Consulting fees/advisory boards: Bristol Myers-Squibb, Genentech, Merck & Co., Inc., Novartis Pharmaceuticals Corporation
Contracted research: Bristol Myers-Squibb, GlaxoSmithKline, Merck & Co., Inc., OncoSec Medical Incorporated, Pfizer, Inc.
Ownership interest (stocks/stock options – excluding mutual funds): OncoSec Medical Incorporated

Laura Muttini
Ownership interest (stocks/stock options – excluding mutual funds): Abbott Laboratories, AbbVie Inc

The writer, peer reviewers, and other activity planners have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by educational grants from Genentech and Merck & Co., Inc.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.
Play Video
The trifecta of healthcare improvement: value-based care, quality improvement, and technology.

See how Med-IQ is helping to enhance patient outcomes in these short videos.

Scott Weber, CEO Med-IQ

From Volume to Value-Based Care: The Role of the CME Enterprise

Scott Weber, CEO,
Med-IQ

Allison Gardner, PhD, VP Educational Strategy and Content, Med-IQ

The Value of Quality Improvement and Education to Advance Healthcare

Allison Gardner, PhD,
VP Educational Strategy and Content,
Med-IQ

Dr. Glenn Treisman,
Department of Psychiatry, Johns Hopkins Medical Institute

The Pros and Cons of Technology on the Practice of Medicine

Dr. Glenn Treisman,
Department of Psychiatry,
Johns Hopkins Medical Institute


Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.